US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Protector Forsikring (PK) (PSKRY) 銘柄情報

Protector Forsikring (PK) (PSKRY)

99.50

0.00

(0.00%)

終了 6月12日 5:00AM

Protector Forsikring (PK) (PSKRY) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

99.50

( - )

買値

99.50

売値

99.50

出来高

-

0.00 日の範囲 0.00

84.50 52 週間の範囲 107.39

時価総額

前日終値

99.50

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 244,764

発行済株式数

82,500,000

配当利回り

19 (3.09%)

PER

18.82

1 株当たり利益 (EPS)

24.02

歳入

14.31B

純利益

2.06B

Protector Forsikring ASA, operates as a non-life insurance company, provides general insurance and reinsurance services in Norway, Sweden, Finland, Denmark, the United Kingdom and France. The company provides personal, motor, property, liability, and change of ownership insurances. It offers service... Protector Forsikring ASA, operates as a non-life insurance company, provides general insurance and reinsurance services in Norway, Sweden, Finland, Denmark, the United Kingdom and France. The company provides personal, motor, property, liability, and change of ownership insurances. It offers services to commercial lines of business, public sector, and affinity schemes through insurance brokers and agents. Protector Forsikring ASA was incorporated in 2003 and is headquartered in Oslo, Norway. 詳細を表示

セクター

Finance

業界

Insurance

ウェブサイト

www.protectorforsikring.no

本社

Oslo, Norway

設立

2026

Protector Forsikring (PK) is listed in the Finance sector of the その他OTC with ticker PSKRY. The last closing price for Protector Forsikring (PK) was US$99.50. Over the last year, Protector Forsikring (PK) shares have traded in a share price range of US$ 84.50 to US$ 107.39.

Protector Forsikring (PK) currently has 82,500,000 shares in issue. The market capitalisation of Protector Forsikring (PK) is US$8.21 billion. Protector Forsikring (PK) has a price to earnings ratio (PE ratio) of 18.82.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	99.5	99.5	99.5	101	99.5	DR
12	-7.89	-7.34705279821	107.39	107.39	99.5	42	103.55879808	DR
26	3.85	4.02509147935	95.65	107.39	95.65	40	104.3341206	DR
52	15	17.7514792899	84.5	107.39	84.5	41	96.68615528	DR
156	57	134.117647059	42.5	107.39	42.125907	37	89.58117757	DR
260	57	134.117647059	42.5	107.39	42.125907	37	89.58117757	DR

PSKRY - Frequently Asked Questions (FAQ)

What is the current Protector Forsikring (PK) share price?

The current share price of Protector Forsikring (PK) is US$ 99.50

How many Protector Forsikring (PK) shares are in issue?

Protector Forsikring (PK) has 82,500,000 shares in issue

What is the market cap of Protector Forsikring (PK)?

The market capitalisation of Protector Forsikring (PK) is USD 8.21B

What is the 1 year trading range for Protector Forsikring (PK) share price?

Protector Forsikring (PK) has traded in the range of US$ 84.50 to US$ 107.39 during the past year

What is the PE ratio of Protector Forsikring (PK)?

The price to earnings ratio of Protector Forsikring (PK) is 18.82

What is the cash to sales ratio of Protector Forsikring (PK)?

The cash to sales ratio of Protector Forsikring (PK) is 2.61

What is the registered address of Protector Forsikring (PK)?

The registered address for Protector Forsikring (PK) is Filipstad Brygge 1, Oslo, Oslo, 0252

What is the Protector Forsikring (PK) website address?

The website address for Protector Forsikring (PK) is www.protectorforsikring.no

Which industry sector does Protector Forsikring (PK) operate in?

Protector Forsikring (PK) operates in the Insurance sector

CaptHowdy

CaptHowdy 50秒前

Nice tryb pal, there is NOTHING wrong with updates from company on Twitter. 100s of companies use social media to heighten brand awareness. Jeez get a clue man, that's the way companies reach the investment community in 2026. Caught up in the past again; just like the whole Greg Mitchell nonsense, w

Smile AOT Works

Smile AOT Works 1分前

The formation of aggregated short chains in the bulk of the crude oil plays a similar function as the addition of drag reducing agents to the crude oil.

The addition of DRA causes further issues at the oil refineries.

The most significant aspect of this technology is

Ranb2khz

Ranb2khz 6分前

Do It Today!

In a class I teach for young adults, I gave the assignment to "go to someone you love, and tell them that you love them." At the beginning of the next class, one of the students began by saying, "I was angry with you last week when you gave us this assignment. I didn't fe

Golden Cross

Golden Cross 9分前

🚨 $RITR Flying under the radar~~Global logistics & supply chain play

💰 Strategic investment agreement worth up to $60M
📈 Massive volume expansion
👀 Social engagement exploding
🏗️ Built structure after the first move instead

Golden Cross

Golden Cross 9分前

🚨 $RITR Flying under the radar~~Global logistics & supply chain play

💰 Strategic investment agreement worth up to $60M
📈 Massive volume expansion
👀 Social engagement exploding
🏗️ Built structure after the first move instead

CA Market News

CA Market News 10分前

Rock Tech Lithium Shares Begin Trading on Xetra in GermanyJune 12, 2026 4:00 AM
PR Newswire (Canada) Strengthening presence in global capital markets with combination of listing in Canada and planned trading on NASDAQRock Tech

Yachtmaster

Yachtmaster 15分前

All the GEMS & FACTS are in the latest 10Q filing.

We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program within our broader framework, targetin

knrorrel

knrorrel 21分前

$PAVS WEEEEEEEEEEEEEEEEEEEEEEEE 🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🚀

knrorrel

knrorrel 28分前

PAVS and HKIT HKIT too , both should run hard today. 🔥
imho

10thMountain

10thMountain 42分前

Woohoo! I’m loving being an early investor. I’ve owned Fidelity Contra Fund for many years which holds a 5% stake in pre-IPO shares! Any other FCNTX holders here? If so…did you see the CNBC article out today that mentions FCNTX??

TieetCoolee

TieetCoolee 44分前

I am pleased to announce the Nomination of very Highly Respected Jay Clayton, former Chairman of the Securities and Exchange Commission, the former Head of Sullivan & Cromwell, one of the most prominent and successful Law Firms anywhere in the World, and the current United States Attorney for the So

PC retired

PC retired 45分前

I am somewhat surprised that there has been no action from the authorities on this scam, yet. The other scam that I have been following and hopefully helping to expose is the Astra/Holcomb(also on ADVFN) where an FBI raid was carried out ~1year ago and the FBI are actively looking for scammed invest

10thMountain

10thMountain 47分前

10thMountain

10thMountain 47分前

10thMountain

10thMountain 47分前

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

10thMountain

10thMountain 47分前

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

CA Market News

CA Market News 55分前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
Newsfile

WALL STREET KID

WALL STREET KID 1時間前

$AMC GREAT NEWS! $65 SHORT TERM TARGET!

https://youtu.be/POTxAjR9zXw?si=MhP3WfvvBEVYXiFO

https://x.com/CEOAdam/status/2065056828661080534

CA Market News

CA Market News 1時間前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
ACCESS NewswireInitial Pilot Deployment Targeted for 2026 Across Vertical Data's GPU Cluster and Edge Data Center Pipeline

US Market News

US Market News 1時間前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

US Market News

US Market News 1時間前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

sharkey1

sharkey1 1時間前

So we wait a year, or Accord scores the patent and Elite gets Tentative approval
then things might change .

iHub News

iHub News 1時間前

SpaceX Secures $75 Billion Ahead of Historic Market DebutJune 12, 2026 2:45 AM
IH Market News SpaceX (NASDAQ:

sharkey1

sharkey1 2時間前

THX, very confusing,
google says
None of these products have yet been approved by the FDA, and Elite therefore does not yet market any products. Elite Labs also engages in contract research ...Read more

no harm no foul
If they went to trial now, it would probly t

Libertas

Libertas 2時間前

Thanks for sharing that, too bad most will write it off as nonsense.

🐻

Protector Forsikring (PK)

Triad Guaranty (EM)

Nemaura Medical

Ci Us Money Market Corpo...

JPM US Value Equity Acti...

Defense Metals (QB)

Origin Agritech

1.125% until 11june2031

Agf European Equity Clas...

Nts Lkd Uksed3p Sr 2968 ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。